Zelda Therapeutics Limited - ZLDAF

Zelda Therapeutics Limited, a bio-pharmaceutical company, focuses on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. It has strategic alliances with Knop Laboratories and CannPal Pty Ltd; and partnerships with AusCann Limited and Aunt Zelda’s Inc, as well as the Complutensé University, the Curtin University, and the Telethon Kids Institute. The company is based in Perth, Australia.